We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · February 17, 2021

CDK 4/6 Inhibitors Are Associated With a High Incidence of Thrombotic Events in Breast Cancer

European journal of haematology

 

Additional Info

European journal of haematology
CDK 4/6 Inhibitors Are Associated With a High Incidence of Thrombotic Events in Women With Breast Cancer in Real-World Practice
Eur. J. Haematol. 2021 Feb 02;[EPub Ahead of Print], MT West, CE Smith, A Kaempf, TCL Kohs, R Amirsoltani, J Ribkoff, JL Choung, A Palumbo, Z Mitri, JJ Shatzel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading